PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 83 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $575,000 | +27.5% | 148,176 | +3.2% | 0.03% | +16.0% |
Q3 2017 | $451,000 | -29.8% | 143,595 | -86.4% | 0.02% | -32.4% |
Q2 2017 | $642,000 | -5.3% | 1,052,770 | +1.0% | 0.04% | -5.1% |
Q1 2017 | $678,000 | +87.8% | 1,042,372 | -10.4% | 0.04% | +69.6% |
Q4 2016 | $361,000 | -43.1% | 1,162,929 | -21.2% | 0.02% | -43.9% |
Q3 2016 | $634,000 | +16.8% | 1,475,396 | -2.2% | 0.04% | +10.8% |
Q2 2016 | $543,000 | -9.0% | 1,508,352 | +6.0% | 0.04% | -14.0% |
Q1 2016 | $597,000 | -37.5% | 1,422,314 | +74.2% | 0.04% | -40.3% |
Q4 2015 | $955,000 | -2.3% | 816,347 | +554.3% | 0.07% | -28.0% |
Q3 2015 | $977,000 | +39.6% | 124,767 | -76.7% | 0.10% | +38.9% |
Q2 2015 | $700,000 | +36.7% | 534,390 | +40.8% | 0.07% | +28.6% |
Q1 2015 | $512,000 | +91.0% | 379,440 | +96.8% | 0.06% | +60.0% |
Q4 2014 | $268,000 | +165.3% | 192,759 | +160.0% | 0.04% | +94.4% |
Q3 2014 | $101,000 | +359.1% | 74,127 | +527.4% | 0.02% | +350.0% |
Q2 2014 | $22,000 | – | 11,815 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BAXTER BROS INC | 148,006 | $206,000 | 0.10% |
First Heartland Consultants, Inc. | 86,204 | $120,000 | 0.07% |
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 671,900 | $934,000 | 0.02% |
Investors Capital Advisory Services | 47,238 | $65,000 | 0.02% |
PINNACLE FINANCIAL PARTNERS INC | 20,000 | $28,000 | 0.01% |
Commonwealth Equity Services, Inc | 481,140 | $669,000 | 0.01% |
REYNOLDS CAPITAL MANAGEMENT LLC | 11,300 | $16,000 | 0.01% |
First Allied Advisory Services, Inc. | 50,000 | $70,000 | 0.01% |
Winslow, Evans & Crocker, Inc. | 13,200 | $18,000 | 0.01% |
AMALGAMATED BANK | 16,650 | $23,000 | 0.00% |